HCPLive

Lawrence Brandt, MD, on Fecal Microbiota Transplant Study, Part I

$shareThis$
Lawrence Brandt, MD, professor of medicine and surgery at the Albert Einstein College of Medicine in New York City, discusses a study on the outcomes of fecal microbiota transplants on almost 100 patients across the country with refractory Clostridium difficile colitis. He explains that 91 percent of the patients experienced prompt relief. Including those who underwent a second transplant or a post-transplant course of medication, 98.3 percent of the patients experienced relief. This video was shot at the annual scientific conference of the American College of Gastroenterology.

Most Popular

Recommended Reading

While children with HIV may have low levels of a key immune cell, a new study shows that most will recover the cell with proper treatment.
Patients administered minimally invasive surgery (MIS) colon resection procedures instead of open surgery leave the hospital quicker and require less follow up with physicians and fewer medical prescriptions.
Researchers will no longer have to test Ebola virus vaccines using the virus strain from the 1976 Zaire outbreak because the results from phase 1 of a new trial are in.
Women afflicted with inflammatory bowel disease (IBD) are at higher risk for cervical dysplasia and cancer.
$vacMongoViewPlus$ $vAR$